To evaluate the clinical utility of pressure-volume loop analyses during pacemaker/implantable cardioverter defibrillator (ICD) implantations to assess the optimal right ventricular (RV) and/or left ventricular (LV) lead position.
Introduction
Right ventricular (RV) apical pacing has a negative effect on cardiac performance due to induction of an abnormal activation and contraction pattern. 1 -5 In patients with pre-existing left ventricular (LV) dysfunction, long-term RV apical pacing is even associated with an increase in mortality and hospitalizations for heart failure. 6 -8 Also in patients with a normal LV function, RV pacing may increase the incidence of heart failure hospitalization and atrial fibrillation. 9 -11 A number of studies have demonstrated less negative effects on LV function, and improvement of LV function, after alternative RV pacing sites 12 -14 and particularly LV or biventricular pacing. 15 -18 However, the best method to locate the optimal RV and LV pacing sites in individual patients is yet unclear. Experimental studies showed an association between impaired haemodynamics and RV pacing, 19 but acute improvement in cardiac output (CO) and LV dP/dt max when LV pacing or biventricular pacing was applied in heart failure patients with a left bundle branch block (LBBB). 20 -24 Steendijk et al. 25 demonstrated that these haemodynamic improvements in pressure-volume relations were maintained after 6 months of cardiac resynchronization therapy (CRT). Furthermore, Vollmann et al. 26 showed a better augmentation of the LV dP/dt with increasing heart rate during biventricular pacing compared with single-site LV or RV pacing. Hay et al. 27 showed improvement in systolic and diastolic LV function with minimal benefit of RV -LV sequential stimulation. However, in these studies, the LV pacing site was mostly fixed in a lateral position, although there may be imported differences in acute haemodynamic effects at different left-sided pacing sites. 20, 28, 29 In fact, these studies were not designed to determine the most optimal site for the permanent LV lead, but only demonstrated that haemodynamic effects of pacing sites can immediately be monitored.
For the first time, we evaluated the utility of pressure-volume loop analyses during pacemaker/implantable cardioverter defibrillator (ICD) implantations as a guidance to assess the optimal RV or LV pacing location.
Methods
From January 2004, 29 patients were enrolled in this single-centre prospective study from the Isala Klinieken, Zwolle, The Netherlands. Patients were candidates for an upgrade to a biventricular pacemaker or ICD when they were chronically paced in the RV for .1 year and requiring .90% RV pacing. Furthermore, patients had to meet two out of the following three inclusion criteria: LVEF ,40%; an interventricular mechanical delay (IVMD) .30 ms; NYHA functional class II or III. In patients with an LVEF .40%, the upgrade was mainly performed at the time of regular device replacement because of battery end of life.
The study was approved by the Medical Ethics Committee of the Isala Klinieken.
All patients were on optimal medical regimen, including angiotensinconverting enzyme inhibitors and beta-blockers. Ischaemic aetiology of heart failure was defined as a history of prior myocardial infarction, percutaneous coronary intervention, or coronary bypass surgery.
Before the upgrade procedure, the conductance catheter was placed through the femoral artery in the long axis of the LV. For the acquisition and analysis of pressure and volume directly from the LV, the Cardiac Function Laboratory CFL-512 (Leycomw) was used. For this purpose, a 7 French (2.3 mm) pigtail-shaped conductance catheter (Leycomw) with 12 electrodes with a spacing of 10 mm was used. Total LV volume is calculated as the instantaneous sum of the segmental signals. Between electrodes 5 and 6, a solid-state, high-fidelity pressure sensor is mounted to measure instantaneous LV pressure. With this catheter, pressure-and volume-derived indices could be measured as described previously. 30 To convert the relative volumes to absolute volumes, the baseline values were matched with independent volume estimations by two-dimensional echocardiography.
To characterize pump function of the LV, pressure and volume signals were combined to construct pressure -volume loops as depicted in Figure 1 . Each loop represented one cardiac cycle and the different phases of the cardiac cycle can be determined. Calculated haemodynamic parameters included indices of pump function [CO and stroke work (SW), systolic function (LVEF, LV dP/dt max ] and diastolic function [end-diastolic volume (EDV) and pressure, LV dP/dt min ]. The area of the pressure-volume loop represented SW. The end-diastolic volume (EDV) is the maximal volume achieved at the end of filling, whereas the end-systolic volume (ESV) was the minimal volume of the ventricle found at the end of the ejection. The difference between EDV and ESV was the stroke volume. For all indices, the average values were assessed from at least 10 consecutive beats, 20 s after initiating a new pacing configuration. In addition, beats altered by a premature ventricular complex were discarded.
After the puncture of the femoral artery, 2500 E of Heparin was administered intravenously. If necessary, a second dose of 2500 E of Heparin was given after 2 h.
Temporary pacing was performed using the chronic lead(s) in the RV apical position and, if present, in the right atrial appendage. This was combined with a temporary electrode in the RV outflow tract (septal site) and pacing wires in several side branches of the coronary sinus ( Figure 2) . For LV pacing, insulated guide wires (VisionWire, Teflon-coated with a non-isolated 15 mm distal pacing tip and a nonisolated proximal part, Biotronik, Germany) were used to permit unipolar pacing or regular LV pacing leads were used. The LV was divided into four segments in the left anterior oblique 308 projection. After an angiographic evaluation, the 'first choice' target vein in the posterolateral position was determined. Subsequently, the wires were placed, if possible, in the anterior, lateral (lateral or antero-lateral vein), posterior (posterior or postero-lateral vein), and inferior (midcardiac vein) segments of the LV. The right ventricular outflow tract (RVOT) pacing electrode was positioned through the femoral vein, whereas the unipolar pace wires were positioned through the subclavian vein and through a coronary sinus-guiding catheter. Pacing was performed using the ERA 300 PSA (Biotronik Germany) with a biventricular interface (switch box). Pacing parameters were 5.0 V at 0.50 ms and a stable heart rate of 80 or 5 b.p.m. above intrinsic rhythm, providing 100% atrial or ventricular capture. The AV delay was set at 100 ms or at the longest possible AV delay, permitting ventricular pacing, while the interventricular delay (VV delay) was set to 0 ms. Serial pacing was performed with sequential pacing intervals of 1 min in each configuration in all single-site locations (RV apex, RV outflow tract, and different positions left sided) and in bifocal right and biventricular configurations (RV apex in combination with LV pacing). Pacing sites were selected in random order, after testing of each alternative pacing site baseline RV pacing was resumed for at least 1 min. On the basis of the on-line data, the configuration with the best ventricular hemodynamic performance (SW) was chosen as the final lead position. At the end of the procedure, when the LV lead was placed in the final position and the pocket was closed, we optimized the AV delay guided by the pressure -volume loop analysis.
Clinical evaluation
At baseline a clinical evaluation was performed. NYHA score was used to classify heart failure symptoms. Quality-of-life score was assessed using the Minnesota Living with Heart Failure questionnaire. Exercise tolerance was assessed using a cardiopulmonary bicycle exercise test (maximal oxygen uptake, VO 2max ) and the 6 min hall walk test.
Echocardiography
Before implantation, standard two-dimensional echocardiography and Doppler imaging was performed and stored in cine-loop format by well-trained echocardiographists and reviewed by cardiologists who were not involved in the study. Furthermore, the echocardiograms were analysed without reference to previous echocardiographic studies of the patient. The LV EDV and ESV were measured and the LVEF was calculated using Simpson's rule. 31 The severity of mitral regurgitation was assessed and graded semi-quantitatively (scale 0 -4) from orthogonal apical echocardiographic images as the average of the planimetered areas of the Doppler colour flow regurgitant jet within the left atrium and as the ratio of regurgitant jet area to left atrial area. 32 Doppler velocities over the pulmonary valve and aortic valve were determined. IVMD is defined as the time
difference between the LV pre-ejection period and the RV pre-ejection period.
Statistics
Continuous variables are presented as means and standard deviation. Dichotomous variables are presented as frequencies and percentages.
Differences between group means were tested by paired two-tailed Student's t-test. Statistical significance was defined as a P-value of ,0.05. The Statistical Package for the Social Sciences (version 15.0, SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.
Results
A total of 29 patients with a mean age of 70 years (69% male) were enrolled in this study. The mean pacing time prior to the upgrade was 73 + 45 months. Baseline characteristics are summarized in Table 1 . In 20 patients, a biventricular pacemaker and in 9 patients a biventricular ICD was scheduled. Mean LVEF was 34.3 + 9.8%. In eight patients, the LVEF was .40% and in one patient, with a severe mitral regurgitation, LVEF was .50%. Mean paced QRS duration at baseline was 175 + 33 ms. In the optimal LV position, mean QRS duration decreased to 144 + 27 ms during biventricular pacing and slightly increased to 182 + 37 ms during singlesided LV pacing. In all patients the coronary sinus was accessible and a venogram could be performed. The pacing wires or LV leads were positioned in all patients at a minimal of three different positions (dependent on the anatomy of the coronary sinus). There were no complications related to the invasive measurements. In two patients, only dP/dt max , but not pressure-volume relationships, could be analysed because of inadequate volume measurements. In one of these patients the conductance catheter was placed through the inter-atrial septum because of the presence of a mechanical aortic valve. Table 2 shows the mean values of all measurements of the LV function parameters for different pacing sites. Compared with baseline (RV apical pacing), RV outflow tract pacing showed only a small but significant increase in dP/dt max and variable effects on the volumetric parameters (SW, LVEF, and CO). Paired analyses of the best left-sided location during single-sided left or , and LV dP/dt max increased 10.4 + 11.1%. Subgroup analysis showed no significant difference in changes in SW or dP/ dt response between the groups of patients with sinus rhythm or atrial fibrillation at baseline. Table 3 shows the mean acute results of four haemodynamic indices during single-sided LV pacing in four different segments. Compared with baseline SW, dP/dt max , and CO improved significantly during single-sided posterior and lateral pacing. The dP/ dt max also increased significantly during pacing in the anterior position. The number of patients paced in the inferior position was small. Mean changes compared with baseline in SW, LVEF, CO, and LV dP/dt max during single-sided LV pacing in four different LV segments are shown in Figure 4 .
The distribution of the position of the LV leads with the highest haemodynamic response based on highest SW and highest dP/ dt max in the biventricular configuration are shown in Figure 5A and B. In 2 of 29 (7.4%) patients, baseline revealed the highest SW; in 7 of 27 (25.9%), the inferior or lateral position showed the highest SW; and in 20 of 29 (74%) patients, the posterior or lateral position showed the best response. In 14 of 29 (45%) patients, an alternative LV-lead position was chosen by guidance of the highest SW compared with the first choice target vein. At the optimal LV lead pacing location in 18 of 29 (62%) patients, .10% increase of LV dP/dt max was measured and in 24/27 (86%) of the patients .10% increase in SW was achieved. In 20 patients (69%) there was concordance between the best LV lead position on the bases of SW and LV dP/dt max .
. Pressure-volume loop analysis during CRT implants
Discussion and limitations
There is growing concern of the importance of the pacing site, particularly in patients with heart failure. 6 -8 We demonstrated that acute effects on ventricular performance by temporary multisite pacing in different configurations can be safely assessed by pressure-volume loop analyses. With this approach, the optimal pacing site can be chosen based on acute haemodynamic response. Our study demonstrates for the first time that ventricular pacing lead location has a significant impact on the LV performance assessed by SW, LVEF, CO, and LV dP/dt max . RV outflow tract pacing showed a small improvement in LV dP/dt max (4%), but small, non-significant, decreases in SW, LVEF, and CO. RV bifocal pacing showed no improvements at all compared with RV apical pacing. In contrast, single-side LV pacing and biventricular pacing showed a significant improvement of the LV function indices.
Compared with baseline, a 39% increase in SW could be achieved in the optimal left-sided position during biventricular stimulation. Comparing systolic LV function at several left-sided pacing sites revealed substantial inter-and intra-individual differences in LV function between the pacing sites within the coronary sinus. On the basis of SW measurements, the posterior or lateral LV lead position showed the highest individual haemodynamic response in 74% of the patients. But, in 45% of the patients, the final LV lead position deviated from the first choice target location because at an alternative site a higher SW and LV dP/dt max could be achieved. On the basis of dP/dt max, compared with SW, the optimal LV lead position appeared to be more often posterior. In 20 out of 29 patients (69%), there was concordance between the best LV lead position on the basis of SW and LV dP/dt max . The percentage of patients with a favourable RV, anterior, or inferior position was comparable. In case of disagreement between the optimal pacing site between the SW and dP/dt results, the site with the highest SW was chosen. In six patients the first choice postero-lateral target location and best haemodynamic outcome based on SW were in agreement, but phrenic nerve stimulation was present. At that moment, SW measurements were very helpful to choose the best alternative site.
Stroke work was chosen as a selection parameter for the optimal pacing site because this index characterizes global pump function during the whole cardiac cycle. LV dP/dt max represents the systolic function alone during the isovolumetric phase. In our study, both SW and LV dP/dt max improved, but SW changes were more prominent. Furthermore, in some patients, an unexplained improvement in SW was noticed without an improvement in LV dP/dt max . Possibly, not only pressure-related changes, but also volume-related changes play an important role in restoration of a dyssynchronous contraction. It can be considered that also changes in mitral regurgitation can effect volume changes, but we did not measure changes in mitral regurgitation during pacing at the different locations.
Lieberman et al. 19 showed in an experimental study that RV pacing worsened LV function in patients with and without LV dysfunction. However, LV and biventricular pacing increased SW, CO, LVEF, and LV dP/dt max in patients with LV dysfunction. 27 In this study we also confined that after chronic RV apical pacing an acute hemodynamic improvement can be achieved when LV or biventricular pacing is applied. Pressure-volume analyses have been applied in small experimental studies to study the influence of pacing site in patients with and without LBBB. The purpose of this study was to evaluate the acute haemodynamic response at different pacing sites and the feasibility of pressure-volume loopguided implantation. Our study suggests that pressure -volume loop analysis during a pacemaker or ICD upgrade procedure is feasible and useful to select the optimal LV pacing site that results in a significant improvement of SW in 86% of patients.
Study limitations
To keep the experimental protocol limited in time, the influence of changes in AV and VV intervals during LV and biventricular pacing was not studied. For the real-time analysis during the different pacing sites, we selected SW and LV dP/dt max. At present, it is unclear which haemodynamic index is the best predictor for clinical response. In the Discussion, we elucidated our choice for SW instead of dP/dt max. The variables used are dependent of loading conditions. For this reason we performed our measurements in a short period of about 10 min in order to keep the loading conditions as stable as possible. Although RV pacing induces an LBBB, it remains difficult and speculative to extrapolate the findings of this study to patients with heart failure and an acquired LBBB. Patients with an LVEF of .40% are not yet indicated for resynchronization therapy. These patients had to be symptomatic with signs of dyssynchrony on echo. In these patients, the upgrade was mainly performed at the time of regular device replacement because of battery end of life.
We collected no data on total procedure time and fluoroscopy time, and we think that future studies with a larger group of patients should pay attention to duration since longer duration may increase risk of infection. However, increasing experience will decrease the duration of implant. Future studies are required to assess whether this method of acute haemodynamic optimization will influence the long-term clinical outcome.
Conclusion
Pressure-volume loop analysis applied during a pacemaker/ICD implantation guide the choice of the optimal LV pacing site. After chronic RV pacing, significant acute improvements in SW, LVEF, CO, and dP/dt max are achieved when LV pacing or biventricular pacing is applied. Prospective randomized trials are needed to confirm the validity and safety of pressure-volume loop analysis and how this will influence the long-term outcome.
